Extendicare Inc. (TSE:EXE – Get Free Report) has been given an average rating of “Moderate Buy” by the seven research firms that are presently covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating, two have issued a buy rating and two have issued a strong buy rating on the company. The average 1 year price target among analysts that have covered the stock in the last year is C$14.92.
Several research firms recently weighed in on EXE. CIBC set a C$18.00 price objective on shares of Extendicare and gave the stock an “outperform” rating in a report on Monday, September 22nd. National Bank Financial raised shares of Extendicare to a “strong-buy” rating in a research note on Wednesday, July 16th. Cibc World Mkts upgraded Extendicare to a “strong-buy” rating in a research report on Monday, September 22nd. Finally, National Bankshares upped their target price on Extendicare from C$15.45 to C$16.10 and gave the stock an “outperform” rating in a research report on Friday, August 8th.
Read Our Latest Stock Report on EXE
Extendicare Trading Down 1.7%
Extendicare Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Monday, September 15th. Stockholders of record on Monday, September 15th were given a dividend of $0.042 per share. This represents a $0.17 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date was Friday, August 29th. Extendicare’s dividend payout ratio is 50.57%.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Further Reading
- Five stocks we like better than Extendicare
- What Makes a Stock a Good Dividend Stock?
- PayPal Stock: Why Wall Street May Be Undervaluing This Giant
- Insider Trades May Not Tell You What You Think
- Why Vertical Aerospace Could Lead the eVTOL Market by 2028
- Expert Stock Trading Psychology Tips
- Is Draganfly’s Army Partnership a Game-Changer for Investors?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.